There’s still time to submit to the MedChemComm web themed issue on Drugs in Middle Space. Guest edited by David Rees (Astex Therapeutics, UK) and Nick Terrett (Ensemble Therapeutics, USA) this issue will feature research and review articles focussing on non-traditional drug molecules that occupy the ‘middle space’ between ‘Rule of 5’ compliant small molecules and biologicals.
Deadline for submission: 30th September 2012
Appropriate topics include the design, synthesis, optimization, modelling, analysis and profiling of peptides, peptidomimetics, macrocycles, natural products, natural product mimetics, and any other molecule in range of approximately 500 to 3000 Daltons. We will seek an emphasis on how this range of structural classes is providing novel approaches to address challenging disease targets and in particular those that might hitherto have been categorised as ‘undruggable’.
Submissions for this issue can be submitted anytime from now until 30th September 2012 using the journal’s online submission system. Please add the phrase ‘Invited article for Drugs in Middle Space’ in the comments to the editor field. All manuscripts will undergo strict peer review and will be assessed using the same criteria as for regular MedChemComm articles.
